Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection
Soo‐Chan Kim(Seoul National University), Andrew Adams(University of Minnesota), Elizabeth Strobert(Emory University), Anish Suri(Bristol-Myers Squibb (United States)), Laura Higginbotham(Emory University), Christian P. Larsen(Emory University Hospital), W. Wakwe(Emory University), Aaron P. Yamniuk(Bristol-Myers Squibb (United States)), Robert Kuhn(Bristol-Myers Squibb (United States)), Alton B. Farris, Cynthia Breeden(Emory University), Laura A. Price(Bristol-Myers Squibb (United States)), Allison Stephenson(Emory University), David V. Mathews(Emory University), Mandy L. Ford(Emory Healthcare), Hui Wang(Beijing University of Chinese Medicine), Karen Price(Purchase College), T. C. Pearson(Emory University), Joe B. Jenkins(Emory University), S J Suchard(Bristol-Myers Squibb (United States)), Steven G. Nadler(Bristol-Myers Squibb (United States))
Cited by 96
Related Papers
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|714
STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4
|Molecular Cancer|2017|568
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384